Literature DB >> 25728041

IL-10 inhibits neuraminidase-activated TGF-β and facilitates Th1 phenotype during early phase of infection.

Avijit Dutta1, Ching-Tai Huang1, Tse-Ching Chen2, Chun-Yen Lin3, Cheng-Hsun Chiu4, Yung-Chang Lin5, Chia-Shiang Chang1, Yueh-Chia He1.   

Abstract

Th1 cells control their activity by producing regulatory IL-10. Here we report that Th1 cell-derived IL-10 facilitates their expansion and, in addition, augments Th1 cell production of IFN-γ, TNF-α and IL-2 during the early phase of influenza. In our antigen-specific mouse experimental system, influenza haemagglutinin-specific CD4(+) T cells respond to infection with the induction of T-bet, and produce both IFN-γ and IL-10. In the early phase of infection, an abundance of viral neuraminidase causes TGF-β activation of haemagglutinin-specific CD4(+) T cells. CD4(+) T-cell-derived IL-10 inhibits neuraminidase-driven TGF-β activation and counteracts the virus-mediated immune suppression. As the host eradicates the virus, neuraminidase activity wanes and IL-10 receptors are upregulated on CD4(+) T cells in the late phase of infection. IL-10 then suppresses immune activation and aids in recovery from infection and inflammation. These results reveal a previously unrecognized function of Th1 cell-derived IL-10 in vivo.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25728041     DOI: 10.1038/ncomms7374

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  14 in total

Review 1.  New fronts emerge in the influenza cytokine storm.

Authors:  Xi-Zhi J Guo; Paul G Thomas
Journal:  Semin Immunopathol       Date:  2017-05-29       Impact factor: 9.623

Review 2.  Influenza A Virus Infection, Innate Immunity, and Childhood.

Authors:  Bria M Coates; Kelly L Staricha; Kristin M Wiese; Karen M Ridge
Journal:  JAMA Pediatr       Date:  2015-10       Impact factor: 16.193

3.  IL-10 Has Differential Effects on the Innate and Adaptive Immune Systems of Septic Patients.

Authors:  Monty Mazer; Jaqueline Unsinger; Anne Drewry; Andrew Walton; Dale Osborne; Theresa Blood; Richard Hotchkiss; Kenneth E Remy
Journal:  J Immunol       Date:  2019-09-09       Impact factor: 5.422

4.  Respiratory Mucosal Proteome Quantification in Human Influenza Infections.

Authors:  Tony Marion; Husni Elbahesh; Paul G Thomas; John P DeVincenzo; Richard Webby; Klaus Schughart
Journal:  PLoS One       Date:  2016-04-18       Impact factor: 3.240

5.  Type I IFN signaling facilitates the development of IL-10-producing effector CD8+ T cells during murine influenza virus infection.

Authors:  Li Jiang; Shuyu Yao; Su Huang; Jeffrey Wright; Thomas J Braciale; Jie Sun
Journal:  Eur J Immunol       Date:  2016-11-09       Impact factor: 5.532

6.  Sterilizing immunity to influenza virus infection requires local antigen-specific T cell response in the lungs.

Authors:  Avijit Dutta; Ching-Tai Huang; Chun-Yen Lin; Tse-Ching Chen; Yung-Chang Lin; Chia-Shiang Chang; Yueh-Chia He
Journal:  Sci Rep       Date:  2016-09-06       Impact factor: 4.379

7.  Rapamycin adjuvant and exacerbation of severe influenza in an experimental mouse model.

Authors:  Ching-Tai Huang; Chen-Yiu Hung; Tse-Ching Chen; Chun-Yen Lin; Yung-Chang Lin; Chia-Shiang Chang; Yueh-Chia He; Yu-Lin Huang; Avijit Dutta
Journal:  Sci Rep       Date:  2017-06-23       Impact factor: 4.379

Review 8.  Intestinal microbiota: a new force in cancer immunotherapy.

Authors:  Zhujiang Dai; Jingqiu Zhang; Qi Wu; Huiwen Fang; Chunfeng Shi; Zhen Li; Chaobiao Lin; Dong Tang; Daorong Wang
Journal:  Cell Commun Signal       Date:  2020-06-10       Impact factor: 5.712

Review 9.  Surviving Deadly Lung Infections: Innate Host Tolerance Mechanisms in the Pulmonary System.

Authors:  Meredith J Crane; Kayla M Lee; Ethan S FitzGerald; Amanda M Jamieson
Journal:  Front Immunol       Date:  2018-06-22       Impact factor: 7.561

10.  Allergic Airway Disease Prevents Lethal Synergy of Influenza A Virus-Streptococcus pneumoniae Coinfection.

Authors:  Sean Roberts; Sharon L Salmon; Donald J Steiner; Clare M Williams; Dennis W Metzger; Yoichi Furuya
Journal:  mBio       Date:  2019-07-02       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.